The AMYPAD consortium would like to congratulate Marthe Smedinga and Fiona Heeman on successfully defending their PhD thesis. On 5 October, Marthe Smedinga (Radboud University Medical Centre, Netherlands) successfully defended her PhD thesis entitled “Diseased without symptoms. The moral desirability of Alzheimer biomarker testing”. Marthe was supervised by Prof. Dr. C. Klijn, Prof. Dr. M. Schermer and Prof. Dr. E. Richard. In her thesis, Marthe, investigated whether testing Alzheimer biomarkers in clinical practice is desirable, through a literature review and interviews with physicians. She also discussed how the framing of ‘Alzheimer’ can steer the weighing of the arguments in a debate.
Fiona Heeman (Amsterdam UMC, Netherlands) defended her thesis entitled “Quantitative amyloid PET imaging in Alzheimer’s disease – Walking the line between accuracy and simplicity” on November 3 (pictured). Her thesis was supervised by Prof. Dr. A.A. Lammertsma, Dr. Ir. M.M. Yaqub and Dr. I. Lopes Alves. The overall aim of her thesis was to evaluate to what extent approaches for quantification of Aβ pathology using PET can be simplified, within the context of different applications. The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA. This article reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
https://amypad.eu/news/recent-news/congratulations-to-marthe-and-fiona-for-their-phd-thesis-defence/
